Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The mechanism is elegant: mimic a gut hormone that tells your brain you are full, and appetite drops dramatically
New England Journal of Medicine, 393(11), 1077-1087
How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
Different pharmacies may use slightly different ingredients or testing methods, which is why some say 28 days and others say 30 days
Our antibodies allow for the tracking of receptor dynamics in real-time across diverse immune phenotypes
:max_bytes(150000):strip_icc()/Health-GettyImages-2187000770-0677e00e83464cab947191790a5ef595.jpg)
